NYT: Johnson & Johnson's COVID-19 booster shot provides strong protection against Omicron
The study, found that two shots of the vaccine reduced the risk of hospitalization from Omicron by about 85%.
•
Dec 30, 2021, 10:58 AM
•
Updated 1,308 days ago
Share:
More Stories
0:22
Cold Spring Village Hall closed due to COVID-19 surge and staff shortages
324ds ago
Hometown Heroes in the Hudson Valley
371ds ago1:28
Medical experts recommend to still take precautions following CDC's revised COVID isolation guidelines
515ds ago1:52
Judge: 3 men convicted in COVID-19 relief aid fraud
536ds ago1:47
Wondrous Things store in Briarcliff Manor to close after 34 years; everything 25% off
663ds ago0:28
Rockland small businesses get COVID-19 reimbursement grant
664ds ago0:22
Cold Spring Village Hall closed due to COVID-19 surge and staff shortages
324ds agoHometown Heroes in the Hudson Valley
371ds ago1:28
Medical experts recommend to still take precautions following CDC's revised COVID isolation guidelines
515ds ago1:52
Judge: 3 men convicted in COVID-19 relief aid fraud
536ds ago1:47
Wondrous Things store in Briarcliff Manor to close after 34 years; everything 25% off
663ds ago0:28
Rockland small businesses get COVID-19 reimbursement grant
664ds agoJohnson & Johnson's COVID-19 booster shot is said to provide strong protection against the Omicron variant, and greatly reduces the risk of hospitalization, according to a clinical trial in South Africa, the New York Times says.
The study, found that two shots of the vaccine reduced the risk of hospitalization from Omicron by about 85%.
More from News 12
1:31
What's Cooking: Uncle Giuseppe's Marketplace's prime rib roast
1:27
What's Cooking: Uncle Giuseppe's quiche lorraine
2:34
Guide: Safety tips to help prevent home burglaries
0:48
How to protect yourself against frostbite during arctic chill
2:19
Guide: Safety measures to help prevent fires and how to escape one
2:07
